| Literature DB >> 34394902 |
Xiangmei Xie1, Jie Fan1, Huihong Chen1, Ling Zhu1, Ting Wan1, Jixin Zhou1, Donghua Fan1, Xiaoying Hu2.
Abstract
With the popularization of medical knowledge and the development of medical technology, people pay more and more attention to COPD. This paper mainly studies the effect of virtual reality technology combined with comprehensive lung rehabilitation on patients with stable chronic obstructive pulmonary disease. 60 patients with stable chronic obstructive pulmonary disease were selected to collect their general information, such as name, gender, and age. They were divided into the experimental group and control group, 30 patients in each group. The experimental group was treated with virtual reality technology combined with lung rehabilitation, while the control group was treated with conventional rehabilitation. Patients in both groups needed medication and participated in a 30-minute disease description activity once a week. In addition, patients in the control group should walk for 20 minutes every day to monitor muscle fatigue. Breathing exercises are also carried out regularly. Patients are instructed to use their lips and abdomen for 5 minutes each time. The respiratory rate was 7 beats per minute. In addition to the routine training of the control group, the experimental group will also train the simulated bicycle for 20 minutes, which will be automatically saved on the computer after the training. After the experiment, the muscle function and motor ability of the two groups were evaluated, and the results were statistically analyzed. The total self-efficacy scores of patients before and after telemedicine technical support increased significantly (2.15 ± 0.21 before telemedicine technical support, 2.39 ± 0.20 after telemedicine technical support), and the difference was statistically significant (P < 0.05). The results show that the application of virtual reality technology can improve the rehabilitation belief of patients and strengthen the training effect.Entities:
Mesh:
Year: 2021 PMID: 34394902 PMCID: PMC8356004 DOI: 10.1155/2021/9987200
Source DB: PubMed Journal: J Healthc Eng ISSN: 2040-2295 Impact factor: 2.682
Figure 1Chronic obstructive lung characteristics (picture source: http://alturl.com/huh5i).
Figure 2The patient's participation.
Figure 3Changes in self-efficacy before and after telemedicine technical support.
Comparison of lung function between the two groups of subjects before and after intervention.
| Index | Group | Before intervention | Intervention for 3 months | Intervention for 6 months |
|
|---|---|---|---|---|---|
| FEV1%pred | Intervention group | 45.42 ± 5.82 | 50.02 ± 6.62 | 53.60 ± 16.39 | 57.959 |
| Control group | 45.63 ± 5.58 | 45.29 ± 5.94 | 43.88 ± 6.04 | ||
|
| |||||
| FEV1/FVC | Intervention group | 59.92 ± 5.88 | 63.42 ± 4.63 | 65.17 ± 4.33 | 17.253 |
| Control group | 60.27 ± 6.18 | 59.52 ± 6.28 | 57.63 ± 6.32 | ||
Figure 4The lungs of patients with COPD (picture source: http://alturl.com/oiab7).
Changes in respiratory rate (RR) of subjects with COPD.
| RR (bpm) | Before exercise | During exercise | After exercise |
|---|---|---|---|
| 9 cm H2O | 14.2 | 11.4 | 13.6 |
| 20% MIP | 13.9 | 11.5 | 15.1 |
| 30% MIP | 14.0 | 11.3 | 13.8 |
| 40% MIP | 14.3 | 10.9 | 14.3 |
| 50% MIP | 13.3 | 10.7 | 15.4 |
| 60% MIP | 14.0 | 11.9 | 16.3 |
Comparison of lung function between the two groups before intervention.
| Grouping |
| Social security | Agricultural insurance | No medical insurance |
|
|
|---|---|---|---|---|---|---|
| Test group | 30 | 20 (66.67%) | 7 (23.33%) | 3 (10.00%) | 0.74 | 0.690 |
| Control group | 30 | 23 (76.67%) | 5 (16.67%) | 2 (6.67%) | ||
| Total | 60 | 43 (71.67%) | 12 (20.00%) | 5 (8.33%) |
Figure 5Lung conditions of patients with stable COPD (picture source: http://alturl.com/jh8jc).
Figure 6The current quality of life of COPD patients at different stages of pulmonary rehabilitation exercise behavior (picture source: http://alturl.com/7fa9j).
Phase comparison of pulmonary rehabilitation and general exercises.
| Exercise behavior stage | 3 months after intervention | 6 months after intervention | 9 months after intervention | |||
|---|---|---|---|---|---|---|
| Control group | Test group | Control group | Test group | Control group | Test group | |
| Preintent exercise | 10 (12.99) | 16 (20.78) | 8 (10.39) | 3 (3.90) | 3 (3.90) | 1 (1.30) |
| Intentional exercise phase | 20 (25.97) | 21 (27.27) | 15 (19.48) | 6 (7.79) | 16 (20.78) | 3 (3.90) |
| Prepare to implement the exercise phase | 15 (19.48) | 14 (18.18) | 20 (25.97) | 29 (37.66) | 19 (24.68) | 12 (15.58) |
| Exercise action phase | 16 (20.78) | 12 (15.58) | 18 (23.38) | 13 (16.88) | 18 (23.38) | 18 (23.38) |
| Maintain the exercise phase | 16 (20.78) | 14 (18.18) | 16 (20.78) | 26 (33.77) | 21 (27.27) | 43 (55.84) |
Figure 7Comparison of CAT scores in the management group before and after management in the comprehensive evaluation group.
Test indicators related to subjects' lung function.
| Vital capacity (L) | FVC (L) | FEV1 (L) | FEV1% | FEV1/FVC (%) | Heart rate | |
|---|---|---|---|---|---|---|
| Before experiment | 2.50 ± 0.04 | 2.44 ± 0.04 | 1.25 ± 0.01 | 54.92 ± 1.24 | 51.08 ± 0.60 | 62.92 ± 1.16 |
| 2.23 ± 0.01 | 2.00 ± 0.02 | 1.03 ± 0.01 | 55.50 ± 1.29 | 51.44 ± 0.24 | 65.00 ± 0.82 | |
|
| ||||||
| In experiment | 2.49 ± 0.04 | 2.44 ± 0.04 | 1.25 ± 0.01 | 55.00 ± 0.60 | 51.13 ± 0.36 | 63.08 ± 0.90 |
| 2.24 ± 0.01 | 2.01 ± 0.02 | 1.03 ± 0.01 | 55.00 ± 0.82 | 51.49 ± 0.20 | 65.25 ± 0.50 | |
Figure 8Comparison of patients' FEV1 results.